2012
DOI: 10.1016/j.jebdp.2012.03.018
|View full text |Cite
|
Sign up to set email alerts
|

Total Diagnostic Delay in Oral Cancer may be Related to Advanced Disease Stage at Diagnosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 9 publications
0
6
0
Order By: Relevance
“…Most cancer research communities continue to agree that early detection is important for providing appropriate treatment to reduce disease burdens and mortality rates. [ 48 , 49 ] In this study, we did not raise awareness of “delay” in terms of this term's linguistic definition or categorization, both of which have been inconsistent across numerous studies. We instead determined the average interval between initial diagnosis and treatment among patients with oral cancer.…”
Section: Discussionmentioning
confidence: 77%
“…Most cancer research communities continue to agree that early detection is important for providing appropriate treatment to reduce disease burdens and mortality rates. [ 48 , 49 ] In this study, we did not raise awareness of “delay” in terms of this term's linguistic definition or categorization, both of which have been inconsistent across numerous studies. We instead determined the average interval between initial diagnosis and treatment among patients with oral cancer.…”
Section: Discussionmentioning
confidence: 77%
“…Disease stage is also considered an outcome of interest for research under this topic as it correlates well with patient survival . A meta‐analytical study has reported total diagnostic delay in oral and oropharyngeal cancer may be related to advanced stage at diagnosis . but some of the case series in this study included oropharyngeal locations as well as other nonoral sites .…”
Section: Discussionmentioning
confidence: 99%
“…11 Currently, more than 60% of patients with HNC present and receive a diagnosis of advanced-stage (III or IV) lesions with a mean 5-year survival rate of 50%. 11,12 This is in contrast to pa-tients with a diagnosis of early-stage disease, for whom the 5-year survival rate is in excess of 80%. 12 Our current data mirror this trend, with more than 80% of our patients presenting at an advanced stage.…”
Section: Discussionmentioning
confidence: 99%